Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 9/20 | 0.60 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.45 |
| ▸ | APP | P05067 | 2/20 | 0.45 |
| ▸ | SNCA | P37840 | 1/20 | 0.45 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.44 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodomethane SCHEMBL4424533 | 1.00 | MAPT (0.60) | MAPTNPC1RAB9AMEN1KMT2A | |
| SCHEMBL12432783 | 0.95 | MAPT (0.65) | MAPTNPC1RAB9AMEN1KMT2A | |
| Iodomethane SCHEMBL3453060 | 0.85 | MAPT (0.59) | MAPTNPC1RAB9AMEN1KMT2A | |
| Iodomethane SCHEMBL5515176 | 0.79 | MAPT (0.52) | MAPTPTGS2APPSNCATRIM24 | |
| Hydrochloric Acid SCHEMBL4787579 | 0.78 | MAPT (0.62) | MAPTNPC1RAB9AMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL2637855 | 0.78 | MAPT (0.62) | MAPTNPC1RAB9AMEN1KMT2A | |
| Hydrochloric Acid SCHEMBL2637856 | 0.78 | MAPT (0.62) | MAPTNPC1RAB9AMEN1KMT2A | |
| SCHEMBL10771126 | 0.77 | PTGS2 (0.59) | MAPTNPC1RAB9AMEN1KMT2A | |
| SCHEMBL28595722 | 0.77 | KMT2A (0.80) | MAPTNPC1RAB9AMEN1KMT2A | |
| SCHEMBL29419010 | 0.77 | KMT2A (0.80) | MAPTNPC1RAB9AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8124626-B2 | Methods of treating inflammations and infections with pyridinium salts | MYCOSOL, INC. (US) | 2012-02-28 | — | — | US | disclosed |
| US-20100267716-A1 | METHODS OF TREATING INFLAMMATIONS AND INFECTIONS WITH PYRIDINIUM SALTS | KLEIN RICHARD B | 2010-10-21 | — | — | US | disclosed |
| US-7547444-B1 | Methods for controlling fungi and bacteria | MYCOSOL, INC. (US) | 2009-06-16 | — | — | US | disclosed |
| WO-2008088917-A2 | METHODS OF USING PYRIDINIUM AND THIAZOLIUM COMPOUNDS AS REAGENTS, DIAGNOSTIC COMPOUNDS AND THERAPEUTIC AGENTS | MYCOSOL, INC. (US) | 2008-07-24 | — | — | WO | disclosed |
| US-7220761-B2 | Compounds and methods for controlling fungi, bacteria and insects | MYCOSOL, INC. (US) | 2007-05-22 | — | — | US | disclosed |
| US-20040235898-A1 | Compounds and methods for controlling fungi, bacteria and insects | MYCOSOL, INC. | 2004-11-25 | — | — | US | disclosed |
| US-20040224984-A1 | Methods of treating inflammations and infections with pyridinium salts | MYCOSOL, INC. | 2004-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040235898-A1 | Compounds and methods for controlling fungi, bacteria and insects | BLVRB, PNPO, PLPBP | MAPT 1618/4885NPC1 3954/4885RAB9A 3091/4885 |
| US-20100267716-A1 | METHODS OF TREATING INFLAMMATIONS AND INFECTIONS WITH PYRIDINIUM SALTS | PNPO, PLPBP, TPMT | MAPT 2157/4885NPC1 3038/4885RAB9A 4725/4885 |
| US-20040224984-A1 | Methods of treating inflammations and infections with pyridinium salts | PNPO, PLPBP, TPMT | MAPT 2157/4885NPC1 3038/4885RAB9A 4725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.